Sanatan Shreay

Sanatan Shreay

Gilead Sciences Inc. - California / United States
Economics & Econometrics / Economics
AD Scientific Index ID: 4381697
-
person_outline Sanatan Shreay's MOST POPULAR ARTICLES
1-) Comorbidities among US patients with prevalent HIV infection—a trend analysisJ Gallant, PY Hsue, S Shreay, N MeyerThe Journal of infectious diseases 216 (12), 1525-1533, 20171782017
2-) Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare dataR Loomba, R Wong, J Fraysse, S Shreay, S Li, S Harrison, SC GordonAlimentary pharmacology & therapeutics 51 (11), 1149-1159, 2020702020
3-) Efficacy and safety of idelalisib in patients with relapsed, rituximab-and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 studyG Salles, SJ Schuster, S De Vos, ND Wagner-Johnston, A Viardot, ...Haematologica 102 (4), e156, 2017702017
4-) Culture and beer preferencesJJ McCluskey, S ShreayThe economics of beer, 161-170, 2011382011
5-) Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in ItalyS Petta, J Ting, S Saragoni, L Degli Esposti, S Shreay, ML Petroni, ...Nutrition, Metabolism and Cardiovascular Diseases 30 (6), 1014-1022, 2020302020